Who We Are

Gold Standard Diagnostics Frankfurt GmbH is a leading healthcare provider of diagnostic solutions with extensive experience in the clinical market. The company provides automated platforms and a broad menu of tests in the fields of virology, bacteriology, parasitology, mycology, hormones, autoimmune diseases, and more recently, in oncology. In 2026, the offer is expanding with a wide range of advanced molecular diagnostic solutions.

 

We are fully committed to enhancing patient care by dedicating our efforts to innovative development, quality manufacturing, and outstanding commercialization of diagnostic solutions throughout our global network of partners. 

Our aim is to be at the forefront of what the laboratories need, and we are committed to delivering best-in-class assays and services to our vast network worldwide.

 

New Chemiluminescence Product Line!

Hurricane DxTM is our new product line consisting of a fully automated random-access chemiluminescence (CLIA) system and a comprehensive assay menu of reagents, featuring 29 assays for autoimmune disease diagnostics.

Furthermore, we will continuously expand our test portfolio to include new assays for infectious diseases including TORCH, EBV, vaccine preventable diseases, and more.

Latest News

4/29/2026
ESCMID 2026 - Munich
We were pleased to participate in ESCMID 2026 in Munich, where we experienced a few engaging and productive days of exchange with the global diagnostics community.
Read more »
2/16/2026
WHX Labs Dubai 2026
We have just wrapped up an incredible four days at WHX Labs Dubai, and we were thrilled to see our booth filled with visitors and engaging conversations throughout the event!
Read more »
11/28/2025
Thank you for visiting us at MEDICA 2025!
We were delighted to take part in MEDICA 2025, and to welcome so many visitors to our booth in Düsseldorf. MEDICA once again proved to be an outstanding platform for meaningful, in-person exchanges, insightful discussions, and the sharing of ideas that drive innovation in diagnostics.
Read more »